Mirati Therapeutics Știri Eulerpool

Mirati Therapeutics Știri Acțiune

Mirati Therapeutics este urmărit de numeroși jurnaliști și investitori din întreaga lume. Cele mai recente Mirati Therapeutics știri le adunăm aici.

• 11 martie ·

  Nasdaq
  Pre-market Movers: EXN, ONE, TLYS, IMVT, LAZY…
• 4 martie ·

  CNBC
  Disney+ to launch cheaper ad-supported tier later this year
• 28 februarie ·

  Thefly.com
  Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00)
• 17 februarie ·

  GuruFocus
  Suvretta Capital Management, Llc Buys Microsoft Corp, Monster Beverage Corp, Hilton Worldwide Holdings Inc, Sells Twilio Inc, Mastercard Inc, Adobe Inc
• 16 februarie ·

  Yahoo
  What You Need To Know About The Mirati Therapeutics, Inc. (NASDAQ:MRTX) Analyst Downgrade Today
• 15 februarie ·

  Yahoo
  U.S. Food and Drug Administration (FDA) Accepts Mirati Therapeutics' New Drug Application for Adagrasib as Treatment of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer
• 10 februarie ·

  CNBC
  'Incredible beat' in Disney's park business wows Wall Street analysts
• 9 februarie ·

  GuruFocus
  Stenahm Asset Managment Ltd Buys Canadian Pacific Railway, Match Group Inc, PayPal Holdings Inc, Sells Booking Holdings Inc, Taiwan Semiconductor Manufacturing Co, Visa Inc
• 1 ianuarie ·

  DowJones
  How the election can affect your investments